Aktiesnakken — Juni 2013

[JKY_VH]

hvilken Mumtaz?

[Mumtaz]

Novo Nordisk: Federal Circuit Court rules on patent litigation involving Prandin (repaglinide)

[Mumtaz]

Bagsværd, Denmark & Plainsboro, NJ 18 June 2013 - Today, the U.S. Court of Appeals for the Federal Circuit partially affirmed a 2011 District Court decision, with a 2-1 ruling that a claim in a Novo Nordisk patent related to the use of repaglinide in combination with metformin for the treatment of type 2 diabetes was invalid. This decision favors approval and launch of a generic repaglinide product.

The Federal Circuit also reversed, with a unanimous 3-0 ruling, the District Court decision that

[Mumtaz]

aner ikke hvad det betyder

[JKY_VH]

Er det ikke den der var fremme tidligere. Novo tabte med 2-1?

[Mumtaz]

den er lige kommet på mail hos mig

[Mumtaz]

21.53

[Mumtaz]

men tak bio

[Mumtaz]

The Federal Circuit also reversed, with a unanimous 3-0 ruling, the District Court decision that Novo Nordisk had committed inequitable conduct during the time the company attempted to acquire the patent.

[Mumtaz]

3-0

[JKY_VH]

Desværre langt mellem snapsene i Novo pt.

[Mumtaz]

og den er lige kommet under aktienyheder 22.08

[Mumtaz]

selvom klokken er 21.59

[Mumtaz]

http://www.proinvestor.com/aktienyt/HUG1710376/Novo-Nordisk-AS-:-Federal-Circuit-Court-afsiger-dom-i-patentsag-om-Prandin-(repaglinid)

[Mumtaz]

nordea får da også stryg i morgen

[JKY_VH]

det gør de og havde da også pli nok til at lukke for aftenhandlen i deres egen aktie.

[Mumtaz]

[Mumtaz]

spændende hvornår man skal samle den op

[JKY_VH]

svært at sige. I genmab skulle man jo ikke skynde sig:-)

[Mumtaz]

ja så venter nok også lidt